Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08HGY
|
||||
Former ID |
DIB005659
|
||||
Drug Name |
Naronapride
|
||||
Synonyms |
Naronapride dihydrochloride; ATI-7500; ATI-7505; Cisapride analog, ARYx Therapeutics; ATI-7000 series, ARYx Therapeutics; Cisapride analog, Procter & Gamble; ATI-7000 series, Procter & Gamble; 5-HT 4 receptor agonist (oral, gastroesophageal reflux/irritable bowel syndrome/gastric motilitydisorder/constipation/dyspepsia), ARYx Therapeutics/Procter & Gamble Pharmaceuticals Inc
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Gastroesophageal reflux disease [ICD9: 140-229, 530; ICD10:K21] | Discontinued in Phase 2 | [547851] | ||
Company |
ARYx Therapeutics
|
||||
Structure |
Download2D MOL |
||||
Formula |
C27H41ClN4O5
|
||||
Canonical SMILES |
c1(cc(c(cc1Cl)C(=O)N[C@H]1[C@H](CN(CC1)CCCCCC(=O)O[C@H]<br />1CN2CC[C@@H]1CC2)OC)OC)N
|
||||
CAS Number |
CAS 860174-12-5
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 4 receptor | Target Info | Agonist | [531812] | |
PathWhiz Pathway | Excitatory Neural Signalling Through 5-HTR 4 and Serotonin | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.